Raptor Pharmaceutical Corp - FORM 10-K - EX-23.2 - EXHIBIT 23.2 - March 2, 2015

Attached files

file filename
EX-31.1 - EXHIBIT 31.1 - Raptor Pharmaceutical Corpex31_1.htm
EX-32.1 - EXHIBIT 32.1 - Raptor Pharmaceutical Corpex32_1.htm
EX-31.2 - EXHIBIT 31.2 - Raptor Pharmaceutical Corpex31_2.htm
EX-23.1 - EXHIBIT 23.1 - Raptor Pharmaceutical Corpex23_1.htm
EX-21.1 - EXHIBIT 21.1 - Raptor Pharmaceutical Corpex21_1.htm
EX-10.46 - EXHIBIT 10.46 - Raptor Pharmaceutical Corpex10_46.htm
EX-10.49 - EXHIBIT 10.49 - Raptor Pharmaceutical Corpex10_49.htm
EX-10.48 - EXHIBIT 10.48 - Raptor Pharmaceutical Corpex10_48.htm
EX-10.50 - EXHIBIT 10.50 - Raptor Pharmaceutical Corpex10_50.htm
EX-10.47 - EXHIBIT 10.47 - Raptor Pharmaceutical Corpex10_47.htm
EXCEL - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpFinancial_Report.xls
10-K - RAPTOR PHARMACEUTICAL, CORP 10-K 12-31-2014 - Raptor Pharmaceutical Corpform10k.htm
EX-10.45 - EXHIBIT 10.45 - Raptor Pharmaceutical Corpex10_45.htm
Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 No. 333-198599, No. 333-195885, No. 333-179215, No. 333-162430, No. 333-166249, No. 333-168966, No. 333-162374 and No. 333-173720 and Form S-8 No. 333-198186, No. 333-190806, No. 333-173719, No. 333-166813, No. 333-163124, No. 333-151859, No. 333-141738, No. 333-138368, No. 333-118729, No. 333-103129, No. 333-98245 and No. 333-48088 of Raptor Pharmaceutical Corp. of our report dated November 13, 2012, relating to the consolidated financial statements of Raptor Pharmaceutical Corp. and its subsidiaries, which appear in Raptor Pharmaceutical Corp.’s Annual Report on Form 10-K for the year ended August 31, 2012 included in this Annual Report on Form 10-K.

Burr Pilger Mayer, Inc.
San Francisco, California
March 2, 2015
 

Raptor Pharmaceutical Corp Reports